NCT01418469View on ClinicalTrials.gov

Disturbances in BCAA Metabolism and the Effects of Feeding and Exercise in COPD

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2004

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DIETARY_SUPPLEMENT

Caseinate

18 mg protein/kg body weight caseinate and 46 mg maltodextrin / kg body weight per 20 min sip feeding

DIETARY_SUPPLEMENT

Whey protein isolate

18 mg protein/kg body weight whey protein isolate and 46 mg maltodextrin / kg body weight per 20 min sip feeding

DIETARY_SUPPLEMENT

Soy

18 mg protein/kg body weight soy and 46 mg maltodextrin / kg body weight per 20 min sip feeding

DIETARY_SUPPLEMENT

soy+BCAA

18 mg protein/kg body weight soy+BCAA and 46 mg maltodextrin / kg body weight per 20 min sip feeding

Trial Locations (1)

Unknown

Maastricht UMC, Maastricht

All Listed Sponsors
collaborator

European Dairy Association (EDA), Brussels

UNKNOWN

lead

Maastricht University Medical Center

OTHER

NCT01418469 - Disturbances in BCAA Metabolism and the Effects of Feeding and Exercise in COPD | Biotech Hunter | Biotech Hunter